Financial Markets | |||||
NEWS | |||||
Is IBD 50 Drugmaker Incyte Stock On The Cusp Of Innovation-Fueled Growth Spurt? With the recent pullback in the stock market, Incyte stock might be poised to fall back within the buy zone above the stock's 89.40 buy point. As long as ...
| |||||
WEB | |||||
Senior Reporter Fitch Solutions' Leveraged Finance Intelligence team is seeking a bright, ambitious Senior Reporter to support our market-leading credit market ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment